Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria
Open Forum Infectious Diseases · 27.09.2024 · 11 (10)
DOI: 10.1093/ofid/ofae575 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 15.10.2024. Verfasst von Ephraim Ogbaini-Emovon und 36 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital, Irrua, Nigeria. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Leibniz Association.
Abstract (Originalsprache)
Background
The standard of care for Lassa fever is the use of ribavirin with supportive therapy. There is little information on the course of viremia and its relationship with clinical outcomes in patients treated with ribavirin.
Methods
We conducted a retrospective analysis of virologic and clinical parameters of 152 reverse transcription polymerase chain reaction–confirmed Lassa fever cases admitted and treated with ribavirin therapy. We describe the Lassa virus RNA kinetics in blood in relation to the clinical course of the patients.
Results
The overall mortality was 9%. The median duration (interquartile range [IQR]) of illness before admission was 8 (5–12) days. Median (IQR) Ct values on admission (t0) were lower among patients who died (21 [20–27]) than in those who survived (34 [30–37]; P < .01). The receiver operating characteristics curve of the association between outcome and Ct value at t0 had a high classification performance, with an AUC of 0.92 (95% CI, 0.86–0.98). The median time to viral clearance (IQR) was 10 (5–15) days. The viral load decreased steadily with the duration of treatment, and all survivors achieved viral clearance within 25 days of hospitalization.
Conclusions
Our study demonstrates that the Ct value on admission has prognostic value and Lassa fever patients treated with ribavirin typically clear the virus within 3–4 weeks of hospitalization. This kinetics has implications for the design of clinical case management and future clinical trial protocols.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
- Department of Pediatrics, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
- Department of Obstetrics and Gynaecology, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
- Department of Community, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
- Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
- Department of Histopathology, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
ORCID-Profile: Ephraim Ogbaini-Emovon, Stephan Günther
Förderung
- The Leibniz Association
Zitieren
APA
Ogbaini-Emovon, E., Akpede, G., Okogbenin, S., Osagiede, E., Tobin, E., Asogun, D., Okokhere, P., Okonofua, M., Akpede, N., Akhideno, P., Erameh, C., Rafiu, M., Azubuike, C., Iraoya, K., Iruolagbe, C., Erohubie, C., Ahmed, D., Ediawe, O., Okoguale, J., …, & Krumkamp, R. (2024). Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria. Open Forum Infectious Diseases, 11(10). https://doi.org/10.1093/ofid/ofae575
Vancouver
Ogbaini-Emovon E, Akpede G, Okogbenin S, Osagiede E, Tobin E, Asogun D, et al. Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria. Open Forum Infectious Diseases. 2024;11(10). doi:10.1093/ofid/ofae575
BibTeX
@article{OgbainiEmovon2024,
author = {Ogbaini-Emovon, Ephraim and Akpede, George and Okogbenin, Sylvanus and Osagiede, Emmanuel and Tobin, Ekaete and Asogun, Danny and Okokhere, Peter and Okonofua, Martha and Akpede, Nosa and Akhideno, Peter and Erameh, Cyril and Rafiu, Mojeed and Azubuike, Chukwuemeka and Iraoya, Kelly and Iruolagbe, Chris and Erohubie, Christian and Ahmed, Dazumi and Ediawe, Osahogie and Okoguale, Joseph and Eifediyi, Reuben and Odia, Ikponmwonsa and Agbukor, Jacqueline and Adomeh, Donatus and Odike, Maxy A C and Ovienria, Wilson and Elkanem, Anieno and Muoebenam, Ekene B and Ojide, Kingsley C and Pallasch, Elisa and Müller, Jonas and Hinzmann, Julia and Günther, Stephan and Pahlmann, Meike and Thielebein, Anke and Duraffour, Sophie and Oestereich, Lisa and Krumkamp, Ralf},
title = {Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria},
journal = {Open Forum Infectious Diseases},
year = {2024},
volume = {11},
number = {10},
doi = {10.1093/ofid/ofae575}
}
EUVIMED